Guest guest Posted November 25, 2008 Report Share Posted November 25, 2008 COPD info Nebulized Perforomist Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI Data from a Phase IIIb clinical trial demonstrate that Perforomist (formoterol fumarate) Inhalation Solution nebulized treatment provided prolonged bronchodilation and increased patient satisfaction compared to albuterol/ipratropium by metered-dose inhaler (MDI). These data were presented today in Philadelphia at CHEST 2008, the annual scientific assembly of the American College of Chest Physicians (ACCP). " COPD patients in this study preferred twice-daily treatment with Perforomist Inhalation Solution nebulized formoterol fumarate over the albuterol/ipratropium combination MDI, " said E. Rand Sutherland, M.D., M.P.H., National Jewish Health and lead clinical investigator. http://tinyurl.com/636xsg Alana Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.